Ching-Kuan Wu

E-Da Hospital

Papers

1

Total Citations

62

H-Index

1

About

Dr. Ching-Kuan Wu is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney cancer treatment. His major contributions lie in the rigorous comparative evaluation of robotic-assisted partial nephrectomy (RaPN) against traditional open surgery. Through a landmark systematic review and meta-analysis of contemporary studies, Dr. Wu synthesized evidence from multiple databases to demonstrate that RaPN offers superior perioperative outcomes, including reduced blood loss, shorter hospital stays, and fewer complications, while maintaining equivalent oncologic efficacy. This seminal work, which has accumulated 62 citations, has helped shift clinical practice toward robotic approaches and provided a robust evidence base for surgeons adopting these technologies. Dr. Wu’s research is characterized by meticulous methodology and a focus on patient-centered outcomes, making him a trusted voice in the field of urologic oncology. His contributions continue to influence surgical guidelines and inspire further investigation into the optimization of nephron-sparing surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
62
Total Citations
62
Avg Citations/Paper
🏆 Most Cited Paper
Open versus robotic partial nephrectomy: Systematic review and meta‐analysis of contemporary studies
62 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: E-Da Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago